Royal Bank of Canada
HALO icon

Royal Bank of Canada’s Halozyme HALO Stock Holding History

Royal Bank of Canada’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$394K – 7149
2020
Q3 		$394K Hold
15,000
– – ﹤0.01% 4061
2020
Q2 		$402K Hold
15,000
– – ﹤0.01% 3955
2020
Q1 		$270K Buy
+15,000
New +$285K ﹤0.01% 4114

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's HALO Position: Q1 2026 in Review

Royal Bank of Canada increased its Halozyme (HALO) stake by 6.6% in Q1 2026, buying an estimated $2.88M and bringing the position to 658,290 shares worth $42.5M. The position accounts for 0.01% of the portfolio, ranked #1000.

Royal Bank of Canada first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.7M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Royal Bank of Canada held 658,290 shares of Halozyme worth $42.5M as of Q1 2026.
  • Royal Bank of Canada bought 40,885 Halozyme shares in Q1 2026, an estimated $2.88M.
  • Halozyme made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1000 holding.
  • Royal Bank of Canada first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Halozyme position peaked at $69.7M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.